Teladoc Health, Inc. provided earnings guidance for the fourth quarter and full year ending December 31, 2023. For the quarter, the company expects revenue of $658 million to $683 million. Net loss per share of $0.33 to $0.23.

For the year, the company expects revenue of $2,600 million to $2,625 million. Net loss per share of $1.50 to $1.40.